期刊
ADVANCED MATERIALS
卷 31, 期 51, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.201904197
关键词
cancer therapy; ferroptosis inducers; iron metabolism; nanomedicine; tumor microenvironment
类别
资金
- National Natural Science Foundation (NNSF) of China [61525402, 61775095]
- Jiangsu Provincial key research and development plan [BE2017741]
- Guangdong Provincial Science and Technology Project [2017B020226001]
- Basic Research Projects of Shenzhen Knowledge Innovation Program [JCYJ20180307123759162]
- General Research Fund of Hong Kong Research Grant Council [CityU_11319516]
Ferroptosis is a newly discovered form of regulated cell death that is the nexus between metabolism, redox biology, and human health. Emerging evidence shows the potential of triggering ferroptosis for cancer therapy, particularly for eradicating aggressive malignancies that are resistant to traditional therapies. Recently, there has been a great deal of effort to design and develop anticancer drugs based on ferroptosis induction. Recent advances of ferroptosis-inducing agents at the intersection of chemistry, materials science, and cancer biology are presented. The basis of ferroptosis is summarized first to highlight the feasibility and characteristics of triggering ferroptosis for cancer therapy. A literature review of ferroptosis inducers (including small molecules and nanomaterials) is then presented to delineate their design, action mechanisms, and anticancer applications. Finally, some considerations for research on ferroptosis inducers are spotlighted, followed by a discussion on the challenges and future development directions of this burgeoning field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据